We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-3 of 3

FDA issues draft guidance on financial disclosure by clinical investigators
  • Hogan Lovells
  • USA
  • July 6 2011

The FDA financial disclosure regulations are designed to help uncover potential investigator bias that may arise due to financial ties between the investigator and the clinical trial sponsor.